论文部分内容阅读
观察贝复舒滴眼液联合糖皮质激素治疗流行性角结膜炎的效果。方法:回顾性分析2013年11月-2014年11月本院收治的86例均为双眼发病的流行性角结膜炎患者的临床资料,按照随机数字表法分为观察组与对照组,每组43例。对照组予以常规治疗,观察组在其基础上加予贝复舒滴眼液联合糖皮质激素治疗,比较两组患者的临床疗效与并发症情况。结果:观察组临床总有效率90.70%高于对照组的74.42%,且并发症发生率0.00%显著低于对照组的76.74%,比较差异均具有统计学意义(P<0.05)。结论:贝复舒滴眼液联合糖皮质激素治疗流行性角结膜炎的效果显著。
To observe the effect of Beifu Shu combined with glucocorticoids in the treatment of epidemic keratoconjunctivitis. Methods: The clinical data of 86 patients with Crohn’s disease who were treated in our hospital from November 2013 to November 2014 were retrospectively analyzed. According to the random number table, the patients were divided into observation group and control group, and each group 43 cases. The control group was given routine treatment. The observation group was given Beifu Shu eye drops combined with glucocorticoid treatment. The clinical efficacy and complications of the two groups were compared. Results: The total effective rate in observation group was 90.70% higher than 74.42% in control group, and the complication rate was 0.00%, which was significantly lower than that in control group (76.74%, P <0.05). Conclusion: Beifu Shu eye drops combined with glucocorticoid treatment of keratoconjunctivitis significant effect.